15 results
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
to patients and could become subject to fines, injunctions or the imposition of civil or criminal penalties. Any of these events could harm Syros’ reputation … , injury to its reputation and significant negative media attention, withdrawal of clinical trial participants, significant costs to defend resulting
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
become subject to fines, injunctions or the imposition of civil or criminal penalties. Any of these events could harm Syros’ reputation, business … reputation and significant negative media attention, withdrawal of clinical trial participants, significant costs to defend resulting litigation
8-K
ji9 5kmx3r5c9yc
19 Jan 21
Other Events
4:00pm
8-K
EX-10.1
c1jufnih9jf9bqh v4m
11 Jan 19
Entry into a Material Definitive Agreement
5:02pm
10-K
ijgwbffny34o28h4pz5
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next